References
1. Cole LA. Biological functions of hCG and hCG-related molecules.Reproductive Biology and Endocrinology. 2010;8. doi:10.1186/1477-7827-8-102 2. Beta-Human Chorionic Gonadotropin, Quantitative, Serum - Mayo Clinic Laboratories | Neurology Catalog. Accessed January 1, 2023. https://neurology.testcatalog.org/show/BHCG 3. Iles RK. Ectopic hCGβ expression by epithelial cancer: Malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol. 2007;260-262. doi:10.1016/j.mce.2006.02.019 4. Inoue N, Watanabe H, Takehara H, Hamazaki M, Kagami S. Refractory pediatric nonrhabdomyosarcoma soft tissue sarcoma associated with ectopic production of beta hCG and hypercalcemia induced by PTHrP.Pediatr Blood Cancer. 2011;57(7). doi:10.1002/pbc.23271 5. Pokharel K, Gilbar PJ, Mansfield SK, Nair LM, So A. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma. Journal of Oncology Pharmacy Practice. 2020;26(5). doi:10.1177/1078155219893428 6. Das P, Crane CH, Eng C, Ajani JA. Prognostic factors for squamous cell cancer of the anal canal. Gastrointest Cancer Res. 2008;2(1). 7. Key Statistics for Anal Cancer. Accessed January 1, 2023. https://www.cancer.org/cancer/anal-cancer/about/what-is-key-statistics.html 8. Yao JN, Zhang XX, Zhou HN, et al. Human papillomavirus related anal squamous cell carcinoma survival: A systematic review and meta-analysis.Transl Cancer Res. 2017;6(3). doi:10.21037/tcr.2017.06.13 9. Types of anal cancer | Cancer Research UK. Accessed January 1, 2023. https://www.cancerresearchuk.org/about-cancer/anal-cancer/stages-types/types 10. Anal Cancer Screening for People at High Risk | OncoLink. Accessed January 1, 2023. https://www.oncolink.org/risk-and-prevention/prevention-screening/anal-cancer-screening 11. Anal Cancer Survival Rates. Accessed January 1, 2023. https://www.cancer.org/cancer/anal-cancer/detection-diagnosis-staging/survival-rates.html 12. Schüler-Toprak S, Treeck O, Ortmann O. Human chorionic gonadotropin and breast cancer. Int J Mol Sci. 2017;18(7). doi:10.3390/ijms18071587 13. Ferreira AR, di Meglio A, Pistilli B, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.Annals of Oncology. 2019;30(11). doi:10.1093/annonc/mdz298 14. Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 2011;125(1-2). doi:10.1016/j.jsbmb.2011.02.001 15. Simpkins F, Garcia-Soto A, Slingerland J. New insights on the role of hormonal therapy in ovarian cancer. In: Steroids. Vol 78. ; 2013. doi:10.1016/j.steroids.2013.01.008 16. Taberna M, Gil Moncayo F, Jané-Salas E, et al. The Multidisciplinary Team (MDT) Approach and Quality of Care. Front Oncol. 2020;10. doi:10.3389/fonc.2020.00085